6.06
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
10.07%
26.89
|
24.43 | 21.93 | 22.90 | 22.81 |
| Operating Income/Loss |
10.07%
-26.89
|
-24.43 | -21.93 | -22.90 | -22.81 |
| Nonoperating Income/Loss |
106.24%
1.885
|
0.914 | 1.16 | 1.369 | 1.556 |
| Net Income/Loss |
6.33%
-25.00
|
-23.52 | -20.77 | -21.53 | -21.25 |
| Basic Average Shares |
59.71%
39.41
|
24.68 | 0.0427 | 24.48 | 24.38 |
| Diluted Average Shares |
59.71%
39.41
|
24.68 | 0.0427 | 24.48 | 24.38 |
| Basic Earnings Per Share |
33.68%
-0.63
|
-0.95 | -0.84 | -0.88 | -0.87 |
| Diluted Earnings Per Share |
33.68%
-0.63
|
-0.95 | -0.84 | -0.88 | -0.87 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):